Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 4:05 PM View:  | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Option Exercise | 1,095 | -- | -- | 15% 7.15K to 8.25K | |
| 14-Aug-24 4:05 PM View: | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Option Sale | 265 | $24.20 | $6,413.00 | (3%) 8.25K to 7.98K | |
| 15-Feb-24 4:17 PM View: | Stoke Therapeutics, Inc. (STOK) | 13-Feb-24 | Option Exercise | 31,739 | $2.19 | $69,508.40 | 100% 0 to 31.74K | |
| 15-Feb-24 4:33 PM View: | Q32 Bio Inc. (QTTB) | 09-Jan-24 | Planned Option Sale | 13,037 | $0.57 | $7,445.43 | (9%) 141.81K to 128.78K | |
| 15-Feb-24 4:33 PM View: | Q32 Bio Inc. (QTTB) | 01-Jan-24 | Option Exercise | 33,420 | -- | -- | 31% 108.39K to 141.81K | |
| 11-Jan-23 4:05 PM View: | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 10,616 | $1.39 | $14,761.50 | (9%) 119.01K to 108.39K | |
| 04-Jan-23 4:36 PM View: | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 33,000 | -- | -- | 38% 86.01K to 119.01K | |
| 02-Dec-22 4:51 PM View: | Akouos, Inc. (AKUS) | 30-Nov-22 | Disposition (change in control) | 26,930 | -- | -- | (100%) 26.93K to 0 | |
| 12-Jan-22 4:05 PM View: | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 5,354 | $3.78 | $20,239.20 | (6%) 91.36K to 86.01K | |
| 12-Jan-22 4:05 PM View: | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 13,860 | -- | -- | 18% 77.5K to 91.36K | |
| 23-Feb-21 5:28 PM View: | Stoke Therapeutics, Inc. (STOK) | 19-Feb-21 | Option Exercise | 10,000 | $2.19 | $21,900.00 | 100% 0 to 10.0K | |
| 23-Feb-21 5:28 PM View: | Stoke Therapeutics, Inc. (STOK) | 19-Feb-21 | Market Option Sale (Planned) | 10,000 | $60.67 | $606,652.00 | (100%) 10.0K to 0 | 56% |
| 25-Nov-20 5:09 PM View: | Stoke Therapeutics, Inc. (STOK) | 23-Nov-20 | Option Exercise | 20,000 | $2.19 | $43,800.00 | 100% 0 to 20.0K | |
| 25-Nov-20 5:09 PM View: | Stoke Therapeutics, Inc. (STOK) | 23-Nov-20 | Planned Option Sale | 20,000 | $46.03 | $920,566.00 | (100%) 20.0K to 0 | |
| 05-Feb-20 4:05 PM View: | Q32 Bio Inc. (QTTB) | 03-Feb-20 | Market Sale (Planned) | 12,500 | $16.16 | $202,021.00 | (14%) 90.0K to 77.5K | 20% |
| 03-Jan-20 5:36 PM View: | Q32 Bio Inc. (QTTB) | 02-Jan-20 | Market Sale (Planned) | 12,500 | $20.50 | $256,191.00 | (12%) 102.5K to 90.0K | 37% |
| 03-Dec-19 4:06 PM View: | Q32 Bio Inc. (QTTB) | 02-Dec-19 | Market Sale (Planned) | 12,500 | $16.25 | $203,176.00 | (11%) 115.0K to 102.5K | 20% |
| 03-Dec-19 4:06 PM View: | Q32 Bio Inc. (QTTB) | 29-Nov-19 | Market Sale (Planned) | 12,500 | $16.04 | $200,559.00 | (10%) 127.5K to 115.0K | 19% |
| 02-Oct-19 4:08 PM View: | Q32 Bio Inc. (QTTB) | 01-Oct-19 | Market Sale (Planned) | 12,500 | $17.40 | $217,468.00 | (9%) 140.0K to 127.5K | 26% |
| 05-Sep-19 4:39 PM View: | Q32 Bio Inc. (QTTB) | 03-Sep-19 | Market Sale (Planned) | 12,500 | $18.75 | $234,320.00 | (8%) 152.5K to 140.0K | 31% |
| 05-Aug-19 4:15 PM View: | Q32 Bio Inc. (QTTB) | 01-Aug-19 | Market Sale (Planned) | 12,500 | $17.37 | $217,111.00 | (8%) 165.0K to 152.5K | 26% |
| 03-Jul-19 4:30 PM View: | Q32 Bio Inc. (QTTB) | 01-Jul-19 | Market Sale (Planned) | 12,500 | $18.98 | $237,300.00 | (7%) 177.5K to 165.0K | 32% |
| 05-Jun-19 6:10 PM View: | Q32 Bio Inc. (QTTB) | 03-Jun-19 | Market Sale (Planned) | 12,500 | $19.86 | $248,262.00 | (7%) 190.0K to 177.5K | 35% |
| 30-Aug-16 4:41 PM View: | Dnib Unwind, Inc. (BIND) | 26-Aug-16 | Option Exercise | 15,000 | $0.44 | $6,600.00 | 100% 0 to 15.0K | |
| 07-Dec-15 5:27 PM View: | OvaScience, Inc. (MLND) | 03-Dec-15 | Grant | 25,000 | -- | -- | 1786% 1.4K to 26.4K | |
| 09-Apr-15 1:29 PM View: | OvaScience, Inc. (MLND) | 09-Apr-15 | Market Purchase | 225 | $28.77 | $6,473.25 | 19% 1.18K to 1.4K | (100%) |
| 08-Apr-15 3:14 PM View: | OvaScience, Inc. (MLND) | 08-Apr-15 | Market Purchase | 175 | $28.04 | $4,907.00 | 17% 1.0K to 1.18K | (100%) |
| 12-Sep-13 8:29 PM View: | OvaScience, Inc. (MLND) | 12-Sep-13 | Market Purchase | 1,000 | $10.32 | $10,320.00 | 100% 0 to 1.0K | (99%) |